Show notes
Regulatory success depends on more than an accurate dossier. In today’s data-driven pharmaceutical environment, inconsistent product information across submissions, labeling, regulatory databases, and lifecycle activities can create submission delays, regulatory queries, rework, and compliance risks.In this episode, we explore why Regulatory Data Quality has become a critical priority for pharmaceutical companies, where data inconsistencies originate, and how poor data quality can impact regulatory submissions and post-approval lifecycle management.We also discuss the growing importance of…
Website: spreaker.com

